Palliative urinary diversion for malignant ureteral obstruction.
An analysis of 62 palliative urinary diversions for malignant ureteral obstruction is presented. The average postoperative survival was 187 days. Cell type, duration of known disease, tumor grade and stage, renal function and previous therapy did not strongly influence survival. Renal function returned to normal in 64 per cent of the azotemic patients. Morbidity and mortality rates were high, largely because of underlying disease and adjuvant therapy . Nearly two-thirds of the patients left the hospital and this group subsequently spent 84 per cent of their remaining survival time at home. A criterion is presented for patient selection and suggestions are made for the selection of an operative procedure.
D000008:Abdominal Neoplasms / Q000150:complications* / Q000401:mortality; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007087:Illinois; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care; D014511:Uremia / Q000209:etiology; D014517:Ureteral Obstruction / Q000150:complications / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D014547:Urinary Diversion / Q000009:adverse effects